ATE388709T1 - Verfahren zur herstellung von 3-amino-8-(1- piperazinyl)-2h-1-benzopyran-2-on und seinen salzen und hydraten - Google Patents
Verfahren zur herstellung von 3-amino-8-(1- piperazinyl)-2h-1-benzopyran-2-on und seinen salzen und hydratenInfo
- Publication number
- ATE388709T1 ATE388709T1 AT05717126T AT05717126T ATE388709T1 AT E388709 T1 ATE388709 T1 AT E388709T1 AT 05717126 T AT05717126 T AT 05717126T AT 05717126 T AT05717126 T AT 05717126T AT E388709 T1 ATE388709 T1 AT E388709T1
- Authority
- AT
- Austria
- Prior art keywords
- benzopyran
- piperazinyl
- hydrates
- salts
- amino
- Prior art date
Links
- AHWHLBJKIFHNIV-UHFFFAOYSA-N 3-amino-8-piperazin-1-ylchromen-2-one Chemical compound C=12OC(=O)C(N)=CC2=CC=CC=1N1CCNCC1 AHWHLBJKIFHNIV-UHFFFAOYSA-N 0.000 title 1
- 150000004677 hydrates Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55595804P | 2004-03-25 | 2004-03-25 | |
| EP04101228 | 2004-03-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE388709T1 true ATE388709T1 (de) | 2008-03-15 |
Family
ID=34928926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05717126T ATE388709T1 (de) | 2004-03-25 | 2005-03-23 | Verfahren zur herstellung von 3-amino-8-(1- piperazinyl)-2h-1-benzopyran-2-on und seinen salzen und hydraten |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7776860B2 (de) |
| EP (1) | EP1732556B1 (de) |
| JP (1) | JP2007530507A (de) |
| AR (1) | AR049478A1 (de) |
| AT (1) | ATE388709T1 (de) |
| CA (1) | CA2554041A1 (de) |
| DE (1) | DE602005005308T2 (de) |
| ES (1) | ES2303674T3 (de) |
| PL (1) | PL1732556T3 (de) |
| SA (1) | SA05260061B1 (de) |
| TW (1) | TWI340136B (de) |
| WO (1) | WO2005092338A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR048112A1 (es) * | 2004-03-25 | 2006-03-29 | Solvay Pharm Bv | Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor |
| JP6061373B2 (ja) * | 2012-07-24 | 2017-01-18 | 国立研究開発法人産業技術総合研究所 | ２−ヒドロキシベンズアルデヒド化合物、これを含有するコラーゲン細胞外分泌阻害剤及び医薬品組成物 |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0189612B1 (de) | 1984-12-21 | 1992-11-04 | Duphar International Research B.V | Arzneimittel mit psychotroper Wirkung |
| IL92544A0 (en) | 1988-12-08 | 1990-08-31 | Duphar Int Res | Piperazine derivatives,their preparation and pharmaceutical compositions containing them |
| US5009895A (en) | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
| FR2670491B1 (fr) | 1990-12-14 | 1993-02-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| PT533268E (pt) | 1991-09-18 | 2002-02-28 | Glaxo Group Ltd | Derivados de benzanilida como antagonistas de 5-ht1d |
| WO1993013766A1 (en) | 1992-01-07 | 1993-07-22 | Merrell Dow Pharmaceuticals Inc. | Treatment of involuntary movements with 5ht1a receptor agonists |
| EP0650964A1 (de) * | 1993-11-02 | 1995-05-03 | Duphar International Research B.V | 1- 2H-1-Benzopyran-2-on-8-yl -Piperazin Derivate |
| US5478572A (en) | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
| NL9401572A (nl) | 1994-09-27 | 1996-05-01 | Avebe Coop Verkoop Prod | Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten. |
| JP3989554B2 (ja) | 1996-03-29 | 2007-10-10 | デユフアー・インターナシヨナル・リサーチ・ベー・ブイ | ピペラジンおよびピペリジン化合物 |
| GB9706089D0 (en) | 1997-03-24 | 1997-05-14 | Scherer Ltd R P | Pharmaceutical composition |
| PA8469101A1 (es) | 1998-04-09 | 2000-09-29 | Pfizer Prod Inc | Ligandos azabiciclicos de receptores 5ht1 |
| US6376494B1 (en) | 1998-06-15 | 2002-04-23 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| US6312717B1 (en) | 1998-07-07 | 2001-11-06 | Bristol-Myers Squibb Company | Method for treatment of anxiety and depression |
| UA62015C2 (en) | 1998-12-28 | 2003-12-15 | Pfizer Prod Inc | Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants) |
| GB0008563D0 (en) | 2000-04-07 | 2000-05-24 | Cambridge Discovery Chemistry | Investigating different physical and/or chemical forms of materials |
| JP2004231514A (ja) | 2000-08-31 | 2004-08-19 | Meiji Seika Kaisha Ltd | ５−ｈｔ７受容体結合能を有し、かつ代謝的に安定なテトラヒドロベンズインドール誘導体 |
| US20030008880A1 (en) | 2001-05-02 | 2003-01-09 | Pfizer Inc. | 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity |
| AR039164A1 (es) | 2002-03-28 | 2005-02-09 | Synthon Bv | Sales de venlafaxina de baja solubilidad en agua |
| FR2837822B1 (fr) * | 2002-03-29 | 2004-06-04 | Bioprojet Soc Civ | Formes polymorphes du fasidotril, leurs procedes de preparation et compositions pharmaceutiques les contenant |
| US20050215551A1 (en) * | 2004-03-25 | 2005-09-29 | Solvay Pharmaceuticals B.V. | 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders |
| AR048112A1 (es) * | 2004-03-25 | 2006-03-29 | Solvay Pharm Bv | Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor |
-
2005
- 2005-03-21 AR ARP050101091A patent/AR049478A1/es not_active Application Discontinuation
- 2005-03-22 SA SA05260061A patent/SA05260061B1/ar unknown
- 2005-03-22 TW TW094108777A patent/TWI340136B/zh not_active IP Right Cessation
- 2005-03-22 US US11/085,136 patent/US7776860B2/en not_active Expired - Fee Related
- 2005-03-23 AT AT05717126T patent/ATE388709T1/de not_active IP Right Cessation
- 2005-03-23 WO PCT/EP2005/051326 patent/WO2005092338A1/en not_active Ceased
- 2005-03-23 PL PL05717126T patent/PL1732556T3/pl unknown
- 2005-03-23 ES ES05717126T patent/ES2303674T3/es not_active Expired - Lifetime
- 2005-03-23 CA CA002554041A patent/CA2554041A1/en not_active Abandoned
- 2005-03-23 JP JP2007504416A patent/JP2007530507A/ja active Pending
- 2005-03-23 EP EP05717126A patent/EP1732556B1/de not_active Expired - Lifetime
- 2005-03-23 DE DE602005005308T patent/DE602005005308T2/de not_active Expired - Lifetime
-
2010
- 2010-07-02 US US12/829,554 patent/US8173660B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2303674T3 (es) | 2008-08-16 |
| JP2007530507A (ja) | 2007-11-01 |
| EP1732556B1 (de) | 2008-03-12 |
| US7776860B2 (en) | 2010-08-17 |
| TWI340136B (en) | 2011-04-11 |
| US20110003830A1 (en) | 2011-01-06 |
| EP1732556A1 (de) | 2006-12-20 |
| US8173660B2 (en) | 2012-05-08 |
| SA05260061B1 (ar) | 2009-01-19 |
| WO2005092338A1 (en) | 2005-10-06 |
| CA2554041A1 (en) | 2005-10-06 |
| US20050215566A1 (en) | 2005-09-29 |
| DE602005005308D1 (de) | 2008-04-24 |
| AR049478A1 (es) | 2006-08-09 |
| DE602005005308T2 (de) | 2009-10-08 |
| TW200611900A (en) | 2006-04-16 |
| PL1732556T3 (pl) | 2008-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE516816T1 (de) | Verfahren zur herstellung von impfstoffen | |
| ATE408609T1 (de) | Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden | |
| DE602005015473D1 (de) | Verfahren und mittel zur herstellung von hyaluronan | |
| ATE408604T1 (de) | Verfahren zur herstellung von 1-alkyl-3- phenyluracilen | |
| ATE533747T1 (de) | Verfahren zur herstellung von tetrahydrochinolinderivaten | |
| DE602005019848D1 (de) | Verfahren zur herstellung von tad- getrocknetem ti | |
| ATE455105T1 (de) | Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten | |
| ATE500824T1 (de) | Verfahren zur reinigung von trans-(-)-delta9- tetrahydrocannabinol und trans-(+)-delta9- tetrahydrocannabinol | |
| EP1773388A4 (de) | Sars-impfstoffe und verfahren zur herstellung von hochaktiven antikörpern | |
| ATE480531T1 (de) | Verfahren zur herstellung von benzopyran-2- olderivaten | |
| DE602004027955D1 (de) | vERFAHREN ZUR HERSTELLUNG VON DEHNBAREN UND STRECKBAREN LAMINATEN | |
| ATE552250T1 (de) | Verfahren zur herstellung von duloxetin und verwandten verbindungen | |
| ATE517898T1 (de) | Verfahren zur herstellung von triazolsubstituierten azaindoloxoessigsäurepiperazinderivaten und dabei hergestellte neue salzformen | |
| ATE453619T1 (de) | Verfahren zur herstellung von hydroperoxiden | |
| ATE461919T1 (de) | Verfahren zur herstellung von montelukast und zwischenprodukte dafür | |
| DE602005010998D1 (de) | Verfahren und einrichtung zur herstellung von metallfolien | |
| ATE406372T1 (de) | Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten | |
| DE502004004318D1 (de) | Verfahren zur herstellung von metall-matrix-verbundwerkstoffen | |
| ATE460414T1 (de) | Verfahren zur herstellung von tiotropiumsalzen | |
| ATE488508T1 (de) | Verfahren zur herstellung von irbesartan und zwischenprodukte davon | |
| DE50303611D1 (de) | Verfahren zur herstellung von polyisobuten | |
| ATE444303T1 (de) | Verfahren zur herstellung von ferrisuccinylcasein | |
| ATE427040T1 (de) | Verfahren zur herstellung von nahrungsmitteln und so hergestelltes nahrungsmittel | |
| ATE433955T1 (de) | Verfahren zur herstellung von aryl- und heteroarylalkylsulfonylhalogeniden | |
| ATE356128T1 (de) | Verfahren zur herstellung von tubulininhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |